Results 291 to 300 of about 103,807 (331)

Role of <sup>18</sup>F-FDG PET/CT in the diagnosis and treatment response assessment of primary pulmonary lymphoma. [PDF]

open access: yesTransl Cancer Res
Pu Y   +11 more
europepmc   +1 more source

Association of CSF visinin-like protein 1 levels with cerebral glucose metabolism among older adults. [PDF]

open access: yesPLoS One
Wang Z   +3 more
europepmc   +1 more source

Role of Fluorodeoxyglucose-PET in Interventional Radiology

PET Clinics, 2022
Fluorodeoxyglucose (FDG)-PET has expanding applications in the field of interventional radiology. FDG-PET provides both qualitative and quantitative assessments of malignancy, infection, and inflammation. These assessments can assist interventional radiologists in selecting the most appropriate treatment options for their oncology patients.
Alireza, Zandifar   +4 more
openaire   +2 more sources

An Appraisal and Update of Fluorodeoxyglucose and Non-Fluorodeoxyglucose-PET Tracers in Thyroid and Non–Thyroid Endocrine Neoplasms

PET Clinics, 2022
Endocrine neoplasms and malignancies are a diverse group of tumors with varied clinical, histopathologic, and functional features. These tumors vary from sporadic to hereditary, isolated entities to multiple neoplastic syndromes, functioning and non functioning tumors, unifocal locally invasive, and advanced to multifocal tumors with disseminated ...
Aadil, Adnan   +3 more
openaire   +2 more sources

Fluorodeoxyglucose PET in Neurology and Psychiatry

PET Clinics, 2014
PET imaging with the most widely available PET tracer, 2-deoxy-2-[(18)F]fluoro-d-glucose (FDG), is a powerful tool in the differential diagnosis of numerous neurologic and psychiatric disorders, particularly in early disease stages. It also plays an important role in the longitudinal evaluation of treatment effects and the depiction of disease courses.
Michael, Schöll   +2 more
openaire   +2 more sources

Brain fluorodeoxyglucose PET in adrenoleukodystrophy

Neurology, 2014
To investigate the cerebral glucose metabolism in subjects with X-linked adrenoleukodystrophy (X-ALD) by using brain [(18)F]-fluorodeoxyglucose PET (FDG-PET).Cross-sectional study in which 12 adults with various forms of X-ALD underwent clinical evaluation and brain MRI, followed by brain FDG-PET, neuropsychological assessment, and personality and ...
Ettore, Salsano   +8 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy